Ando K, Takei N, Matsumoto H, Iyo M, Isoda H, Mori N. Neural damage in
the lenticular nucleus linked with tardive dyskinesia in schizophrenia:
a preliminary study using proton magnetic resonance spectroscopy.
Schizophr Res 57:273-279, 2002.
Fukuda K, Takahashi K, Iwata Y, Mori N, Gonda K, Ogawa T, Osonoe K, Sato
M, Ogata S, Horimoto T, Sawada T, Tashiro M, Yamaguchi K, Niwa S, Shigeta
S.
Immunological and PCR analyses for Borna disease virus in psychiatric patients
and blood donors in Japan.
J Clin Microbiol 39: 419-429, 2000.
Iwata Y, Kotani Y, Hoshino R, Takei N, Iyo M, Mori N. Carbamazepine augmentation
of clomipramine in the treatment of refractory obsessive-compulsive disorder.
J Clin Psychiatry 61: 528-529, 2000.
Iwata Y, Takahashi K, Peng X, Fukuda K, Ohno K, Ogawa T, Gonda K, Mori
N, Niwa S, Shigeta S.
Detection and sequence analysis of borna disease virus p24 RNA from peripheral blood mononuclear cells of patients with mood disorders or schizophrenia and of blood donors.
J Virol 72: 10044-10049, 1998.
Kawai M, Takei N, Mori N.
Morphometry in schizophrenia revisited: height and its relationship to
pre-morbid function.
Psychol Med 29: 753-754, 1999.
Kubo M, Kawai M, Sakuraba S, Mori N, Oguri K, Komoda T.
Psychiatric symptoms in renal transplant patients in relation to alexithymia.
Transplant Proc 33:3698-3699, 2001.
Matsumoto H, Takei N, Kawai M, Saito F, Kachi K, Ohashi Y, Takeuchi H,
Mori N.
Differences of symptoms and standardized weight index between patients
with early-onset and late-onset anorexia nervosa.
Acta Psychiatr Scand 104:66-71, 2001.
Matsumoto H, Takei N, Saito F, Kachi K, Mori N.
The association between obstetric complications and childhood-onset schizophrenia:
a replication study.
Psychol Med 31: 907-914, 2001.
Matsumoto H, Takei N, Saito H, Kachi K, Mori N. Childhood-onset schizophrenia and obstetric complications: a case-control study.
Schizophr Res 38: 93-99, 1999.
Matsumoto H, Takei N, Saito F, Mori N. Marked cognitive decline in a premorbidly
very bright girl after onset of psychosis.
Schizophr Res 44: 157-158, 2000.
Matsunaga T, Tsukada H, Nishiyama S, Sekine Y, Kakiuchi T, Iyo M, Mori
N. Yohimbine increases the binding potential for [11C]flumazenil in the
monkey brain.
J Neural Transm 108:1375-1382, 2001.
Ohashi Y, Okamoto N, Uchida K, Iyo M, Mori N, Morita Y. Daily rhythm of serum melatonin levels and effect of light exposure in patients with dementia of the Alzheimer's type.
Biol Psychiatry 45: 1646-1652, 1999.
Ohashi Y, Okamoto N, Uchida K, Iyo M, Mori N, Morita Y. Differential pattern
of the circadian rhythm of serum melatonin in young and elderly healthy
subjects.
Biol Signals 6:301-306, 1997.
Sakanoue M, Mori N, Takei N, Kawai M, Tani K, Suzuki K, Iwata Y, Sekine
Y, Ashby CR Jr, Minabe Y.
Tacrolimus, a specific inhibitor of calcineurin, modifies the locomotor
activity of quinpirole, but not that of SKF82958, in male rats.
Eur J Pharmacol 438:93-97, 2002.
Sekine Y, Iyo M, Ouchi Y, Matsunaga T, Tsukada H, Okada H, Yoshikawa E, Futatsubashi M, Takei N, Mori N.
Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.
Am J Psychiatry 158: 1206-1214, 2001.
Sekine Y, Iyo M, Tanaka K, Matsuyama K, Matsunaga T, Mori N.
Effective adjunctive use of low-dose methylphenidate with mianserin for major depression with silent cerebral infarction: a case report.
J Clin Psychopharmacol 20:584-585, 2000.
Sekine Y, Minabe Y, Kawai M, Suzuki K, Iyo M, Isoda H, Sakahara H, Ashby
CR Jr, Takei N, Mori N.
Metabolite alterations in basal ganglia associated with methamphetaine-related
psychiatric symptoms. A proton MRS study.
Neuropsychopharmacol 27:453-461, 2002.
Sekine Y, Takei N, Iyo M, Mori N, Minami M, Ohta T.
Effective risperidone treatment for simple deteriorative disorder (simple schizophrenia): a case report.
Schizophr Res 50:213-214, 2001.
Suzuki K, Omura S, Ohashi Y, Kawai M, Iwata Y, Tani K, Sekine Y, Takei N, Mori N.
FK506 facilitates chemical kindling induced by pentylenetetrazole in rats.
Epilepsy Res 46:279-282, 2001.
Takei N.
Why are public-health policies ill made in japan?
Lancet 358: 589, 2001.
Takei N, Inagaki A; JPSS-2 research group.
Polypharmacy for psychiatric treatments in Japan.
Lancet 360: 647, 2002.
Takebayashi H, Takei N, Mori N, Suzuki S.
Unilateral auditory hallucinations in schizophrenia after damage to the
right hippocampus.
Schizophr Res 58:329-331, 2002.
Takei N, Kawai M, Mori N.
Sluggish economics affect health of Japanese 'business warriors'.
Br J Psychiatry 176:494-495, 1999.
Tani K, Iyo M, Matsumoto H, Kawai M, Suzuki K, Iwata Y, Won T, Tsukamoto T, Sekine Y, Sakanoue M, Hashimoto K, Ohashi Y, Takei N, Mori N.
The effects of dentate granule cell destruction on behavioural activity
and Fos protein expression induced by systemic methamphetamine in rats.
Br J Pharmacol 134:1411-1418, 2001.
Tsukamoto T, Iyo M, Tani K, Sekine Y, Hashimoto K, Ohashi Y, Suzuki K,
Iwata Y, Mori N.
The effects of FK506, a specific calcineurin inhibitor, on methamphetamine-induced behavioral change and its sensitization in rats.
Psychopharmacol 158:107-113, 2001.
Yamashita Y, Takei N, Kawai M, Mori N.
Anorexia nervosa as a phenotype of cognitive impairment in schizophrenia.
Br J Psychiatry 174: 558, 1999.
|
主な研究とプロジェクト
